Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-03

Clinical Trial Update: Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (COMARIS) studied whether combining methotrexate with adalimumab affects immunization in patients with ankylosing spondylitis; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University Hospital, Tours | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED